2023
Utilization of PROMIS Neuropathic Pain Quality for Detection and Monitoring Neuropathic Pain in Heel Pain Patients
Joo P, Lee W, Hoffman S, Baumhauer J, Oh I. Utilization of PROMIS Neuropathic Pain Quality for Detection and Monitoring Neuropathic Pain in Heel Pain Patients. Foot & Ankle Orthopaedics 2023, 8: 24730114231213620. PMID: 38058978, PMCID: PMC10697051, DOI: 10.1177/24730114231213620.Peer-Reviewed Original ResearchBody mass indexNeuropathic painPhysical functionNeuropathic pain qualitiesPain interferencePain patientsPain qualityBack/neck painPrevalence of NPWorse pain interferenceOnly independent factorProspective cohort studyTime pointsLow physical functionAnxiety/depressionNeck painHeel painCohort studyAnkle patientsMass indexMean ageInitial screening toolLinear mixed modelingIndependent factorsSelf-efficacy scores
2022
Can We Utilize PROMIS Neuropathic Pain Quality for Assessment of Neuropathic Heel Pain?
Joo P, Hoffman S, Baumhauer J, Oh I. Can We Utilize PROMIS Neuropathic Pain Quality for Assessment of Neuropathic Heel Pain? Foot & Ankle Orthopaedics 2022, 7: 2473011421s00713. PMCID: PMC9666847, DOI: 10.1177/2473011421s00713.Peer-Reviewed Original ResearchBody mass indexBack/neck painNeuropathic painSevere neuropathic painHeel painNeuropathic pain qualitiesPhysical functionPain interferenceT-scoreNeck painPain qualityOnly significant independent factorTertiary care academic institutionLow physical functionOutcomes Measurement Information SystemSignificant independent factorsMeasurement Information SystemNeuropathic mechanismsCurrent smokersMost etiologiesNociceptive painSecondary outcomesCommon presentationInitial visitPain management
2019
Baseline Pain in Adults with Sickle Cell Disease Can be Neuropathic or Nociceptive and Outcomes Differ between Pain Types
Curtis S, Forray A, Hendrickson J, Roberts J. Baseline Pain in Adults with Sickle Cell Disease Can be Neuropathic or Nociceptive and Outcomes Differ between Pain Types. Blood 2019, 134: 1028. DOI: 10.1182/blood-2019-129106.Peer-Reviewed Original ResearchSickle cell diseaseNeuropathic pain qualitiesNeuropathic painNociceptive painPain impactBaseline painED usePain qualityWorse sleepOpioid usePain groupChronic painCell diseaseEpisode frequencyOutcomes Measurement Information System (PROMIS) domainsAdult Sickle Cell QualityAverage daily opioid useHigher C-reactive proteinYale-New Haven HospitalHigh ED useWorse clinical outcomesC-reactive proteinDaily opioid useEmergency department useHalf of adults
2013
Pain Assessment and Measurement in Neonates
Cong X, McGrath J, Cusson R, Zhang D. Pain Assessment and Measurement in Neonates. Advances In Neonatal Care 2013, 13: 379-395. PMID: 24300956, DOI: 10.1097/anc.0b013e3182a41452.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply